{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:08:07Z","timestamp":1785409687639,"version":"3.56.0"},"reference-count":16,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1083172"],"award-info":[{"award-number":["1083172"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["12\/35\/17"],"award-info":[{"award-number":["12\/35\/17"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,11,3]]},"published-print":{"date-parts":[[2021,12]]},"abstract":"\n Introduction<\/jats:title>\n ACOSOG-Z0011(Z11) trial showed that axillary node clearance (ANC) may be omitted in women with \u22642 positive nodes undergoing breast conserving surgery (BCS) and whole breast radiotherapy (RT). A confirmatory study is needed to clarify the role of axillary treatment in women with \u22642 macrometastases undergoing BCS and groups that were not included in Z11 for example, mastectomy and those with microscopic extranodal invasion. The primary objective of POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy (POSNOC) is to evaluate whether for women with breast cancer and 1 or 2 macrometastases, adjuvant therapy alone is non-inferior to adjuvant therapy plus axillary treatment, in terms of 5-year axillary recurrence.<\/jats:p>\n <\/jats:sec>\n \n Methods and analysis<\/jats:title>\n POSNOC is a pragmatic, multicentre, non-inferiority, international trial with participants randomised in a 1:1 ratio. Women are eligible if they have T1\/T2, unifocal or multifocal invasive breast cancer, and 1 or 2 macrometastases at sentinel node biopsy, with or without extranodal extension. In the intervention group women receive adjuvant therapy alone, in the standard care group they receive ANC or axillary RT. In both groups women receive adjuvant therapy, according to local guidelines. This includes systemic therapy and, if indicated, RT to breast or chest wall. The UK Radiotherapy Trials Quality Assurance Group manages the in-built radiotherapy quality assurance programme. Primary endpoint is 5-year axillary recurrence. Secondary outcomes are arm morbidity assessed by Lymphoedema and Breast Cancer Questionnaire and QuickDASH questionnaires; quality of life and anxiety as assessed with FACT B+4\u2009and State\/Trait Anxiety Inventory questionnaires, respectively; other oncological outcomes; economic evaluation using EQ-5D-5L. Target sample size is 1900. Primary analysis is per protocol. Recruitment started on 1 August 2014 and as of 9 June 2021, 1866 participants have been randomised.<\/jats:p>\n <\/jats:sec>\n \n Ethics and dissemination<\/jats:title>\n Protocol was approved by the National Research Ethics Service Committee East Midlands\u2014Nottingham 2 (REC reference: 13\/EM\/0459). Results will be submitted for publication in peer-reviewed journals.<\/jats:p>\n <\/jats:sec>\n \n Trial registration number<\/jats:title>\n \n ISRCTN54765244<\/jats:ext-link>\n ;\n NCT0240168<\/jats:ext-link>\n Cite Now\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-054365","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T11:34:44Z","timestamp":1638444884000},"page":"e054365","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":80,"title":["POSNOC\u2014POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct0240168","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2381-8337","authenticated-orcid":false,"given":"Amit","family":"Goyal","sequence":"first","affiliation":[{"name":"Department of Surgery, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G Bruce","family":"Mann","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Breast Cancer Trials, Newcastle, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Fallowfield","sequence":"additional","affiliation":[{"name":"Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lelia","family":"Duley","sequence":"additional","affiliation":[{"name":"Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Reed","sequence":"additional","affiliation":[{"name":"Brighton and Sussex Medical School, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dodwell","sequence":"additional","affiliation":[{"name":"Nuffield Department of Population Health, Oxford University, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E","family":"Coleman","sequence":"additional","affiliation":[{"name":"Department of Oncology and Metabolism, Weston Park Hospital, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Fakis","sequence":"additional","affiliation":[{"name":"Research and Development, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Newcombe","sequence":"additional","affiliation":[{"name":"Department of Primary Care and Public Health, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Whitham","sequence":"additional","affiliation":[{"name":"Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Childs","sequence":"additional","affiliation":[{"name":"Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Whynes","sequence":"additional","affiliation":[{"name":"School of Economics, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaughan","family":"Keeley","sequence":"additional","affiliation":[{"name":"Lymphoedema Department, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Ellis","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Fairbrother","sequence":"additional","affiliation":[{"name":"Patient Advocate, Independent Cancer Patients\" Voice, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabina","family":"Sadiq","sequence":"additional","affiliation":[{"name":"Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Monson","sequence":"additional","affiliation":[{"name":"Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Montgomery","sequence":"additional","affiliation":[{"name":"Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tan","sequence":"additional","affiliation":[{"name":"Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Vale","sequence":"additional","affiliation":[{"name":"Health Economics Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Homer","sequence":"additional","affiliation":[{"name":"Health Economics Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heath","family":"Badger","sequence":"additional","affiliation":[{"name":"Breast Cancer Trials, Newcastle, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7924-0602","authenticated-orcid":false,"given":"Rachel Helen","family":"Haines","sequence":"additional","affiliation":[{"name":"Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickey","family":"Lewis","sequence":"additional","affiliation":[{"name":"Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Megias","sequence":"additional","affiliation":[{"name":"National Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre, Northwood, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohal","family":"Nabi","sequence":"additional","affiliation":[{"name":"National Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre, Northwood, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetinder","family":"Singh","sequence":"additional","affiliation":[{"name":"National Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre, Northwood, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Caraman","sequence":"additional","affiliation":[{"name":"National Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre, Northwood, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Miles","sequence":"additional","affiliation":[{"name":"National Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre, Northwood, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"2025121400181442000_11.12.e054365.1","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1200\/JCO.2001.19.8.2240","article-title":"Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy","volume":"19","author":"Buchholz","year":"2001","journal-title":"J Clin Oncol"},{"key":"2025121400181442000_11.12.e054365.2","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/bjs.9058","article-title":"Results of a national training programme in sentinel lymph node biopsy for breast cancer","volume":"100","author":"Mansel","year":"2013","journal-title":"Br J Surg"},{"key":"2025121400181442000_11.12.e054365.3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2002.02203.x"},{"key":"2025121400181442000_11.12.e054365.4","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181f08f32"},{"key":"2025121400181442000_11.12.e054365.5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.clbc.2016.05.009","article-title":"Practice patterns of radiation field design for sentinel lymph node-positive early-stage breast cancer","volume":"16","author":"Azghadi","year":"2016","journal-title":"Clin Breast Cancer"},{"key":"2025121400181442000_11.12.e054365.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70460-7"},{"key":"2025121400181442000_11.12.e054365.7","doi-asserted-by":"publisher","DOI":"10.1097\/00006199-200311000-00004"},{"key":"2025121400181442000_11.12.e054365.8","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-013-0362-4"},{"key":"2025121400181442000_11.12.e054365.9","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012278023233"},{"key":"2025121400181442000_11.12.e054365.10","unstructured":"Spielberger C . The manual for the State-Trait inventory. Palo Alto, CA: Consulting Psychologists Press Inc, 1983."},{"key":"2025121400181442000_11.12.e054365.11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24174"},{"key":"2025121400181442000_11.12.e054365.12","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780040211"},{"key":"2025121400181442000_11.12.e054365.13","unstructured":"NHS reference costs . Series \"NHS reference costs\" 2019-2020, 2021. Available: https:\/\/www.england.nhs.uk\/publication\/2019-20-national-cost-collection-data-publication\/"},{"key":"2025121400181442000_11.12.e054365.14","unstructured":"Curtis L , Burns A . Unit costs of health and social care. personal social services research unit. Canterbury: University of Kent, 2020."},{"key":"2025121400181442000_11.12.e054365.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.300.6719.230"},{"key":"2025121400181442000_11.12.e054365.16","unstructured":"National Institute for Health and Care Excellence (NICE): guide to the methods of technology appraisal 2013, 2013. Available: https:\/\/www.nice.org.uk\/article\/pmg9"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-054365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:18:24Z","timestamp":1765700304000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-054365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":16,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,2]]},"published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1136\/bmjopen-2021-054365"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-054365","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}